bioMerieux UK Ltd
Category: Exhibitors 2022
For over 50 years bioMérieux has been developing tests that bring high medical value for clinical decisions in the areas of infectious diseases, cardiovascular emergencies and targeted cancer and most recently syndromic testing.
We also bring progress to laboratories: by increasing automation and improving data management, we are helping to reinforce the efficiency of healthcare structures, increase lab productivity, and reduce healthcare costs.
bioMérieux is determined to continue to play a pioneering role by innovating and designing the diagnostics of the future to address the major challenges for public health worldwide.